Utilizing CRP and D-dimer Levels for Assessing Cerebral Infarction Risk in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Retrospective Analysis - Report - MDSpire
Advertisement
Utilizing CRP and D-dimer Levels for Assessing Cerebral Infarction Risk in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Retrospective Analysis
Clinical Report: Utilizing CRP and D-dimer Levels for Assessing CI Risk in Pediatrics
Overview
Expand on the implications of the findings in the context of current pediatric care practices.
Background
Cerebral infarction is a rare yet serious complication of Mycoplasma pneumoniae pneumonia in children, with potential long-term consequences. Understanding the clinical characteristics and risk factors associated with CI is crucial for early diagnosis and intervention. This study contributes to the limited literature on the relationship between inflammatory and coagulation markers and the risk of CI in pediatric patients with MPP.
Data Highlights
Variable
Odds Ratio (OR)
p-value
CRP
1.08
0.003
D-dimer
1.00026
0.007
Key Findings
Among 2,947 children with MPP, 9 (0.3%) developed CI.
Higher CRP levels were significantly associated with CI (OR = 1.08, p = 0.003).
Higher D-dimer levels were significantly associated with CI (OR = 1.00026, p = 0.007).
The combination of CRP and D-dimer demonstrated good discriminatory performance for CI (AUC = 0.920, p < 0.001).
Thrombosis is a rare but serious extrapulmonary complication of MPP.
Clinical Implications
Clinicians should consider monitoring CRP and D-dimer levels in pediatric patients with MPP to identify those at increased risk for cerebral infarction. Early recognition and intervention may improve outcomes for affected children.
Conclusion
The study underscores the importance of CRP and D-dimer as potential biomarkers for assessing the risk of cerebral infarction in children with Mycoplasma pneumoniae pneumonia. Further research is needed to validate these findings in larger cohorts.
